<code id='413E625ECF'></code><style id='413E625ECF'></style>
    • <acronym id='413E625ECF'></acronym>
      <center id='413E625ECF'><center id='413E625ECF'><tfoot id='413E625ECF'></tfoot></center><abbr id='413E625ECF'><dir id='413E625ECF'><tfoot id='413E625ECF'></tfoot><noframes id='413E625ECF'>

    • <optgroup id='413E625ECF'><strike id='413E625ECF'><sup id='413E625ECF'></sup></strike><code id='413E625ECF'></code></optgroup>
        1. <b id='413E625ECF'><label id='413E625ECF'><select id='413E625ECF'><dt id='413E625ECF'><span id='413E625ECF'></span></dt></select></label></b><u id='413E625ECF'></u>
          <i id='413E625ECF'><strike id='413E625ECF'><tt id='413E625ECF'><pre id='413E625ECF'></pre></tt></strike></i>

          explore

          explore

          author:knowledge    Page View:54236
          Medical bill
          Adobe

          The cyberattack on Change Healthcare has fractured the country’s health care payment infrastructure. But it also exposed how complicated and vital these electronic pipes are.

          Using terms like “clearinghouse” and “electronic data interchange” are quick ways to lose an audience. But Ben Handel, a health economist at the University of California, Berkeley, for the past 13 years, has become intimately familiar with that language. When the Department of Justice sued to block UnitedHealth’s acquisition of Change Healthcare in 2022 — a case the agency ultimately lost — Handel was the government’s witness to explain what could happen to the payments and clearinghouse markets if the deal went through.

          advertisement

          He didn’t get into health economics to study the payment plumbing system, but understanding basic concepts about companies like Change Healthcare can illuminate the gravity of what is going on now. For example, the cyberattack and resulting outage isn’t just leading to a cash crunch for providers. It’s also creating uncertainty about how to handle basic requests to approve drugs and care and verify patients’ insurance.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Deliver public health messages at the right time
          Deliver public health messages at the right time

          AdobeIwas31yearsoldwhenmymotherwasdyingofbreastcancer.Oneday,whilesittingwithherinthehospital,heronc

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          GSK’s asthma push continues as drug succeeds in Phase 3 trials

          AkiraSuemori/APAnewasthmatreatmentthatcouldbeadministeredjustonceeverysixmonthshassucceededintwoPhas